Skip to main content
Clinical Trials/NCT00674895
NCT00674895UnknownPhase 1

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Control and Treatment of Parkinson's Disease.

GAAD Medical Research Institute Inc.2 sites in 1 country10 target enrollmentStarted: May 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Sponsor
Enrollment
10
Locations
2
Primary Endpoint
Cure for PD

Study Overview

Brief Summary

Parkinson's disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. This study will investigate the use of far infrared radiation to manage, control and treat PD.

Detailed Description

Parkinson's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement. The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. PD is both chronic and progressive.

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.

It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have PD.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • People with Parkinson's Disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Cure for PD

Time Frame: 2 years

Secondary Outcomes

  • Rehabilitation of PD Patients(2 Years)

Investigators

Sponsor
GAAD Medical Research Institute Inc.
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials